Welcome to the Shilpee Lab website, where we share our research projects, ideas, photos, and stories.

GCN5 and pATM co-localisation
DNA Fibre_1
DNA Fibre_2
day 4
mice CT

About Us

Dr. Shilpee Dutt, Ph.D.
Principal Investigator
Scientific Officer 'F'

B.Sc: University of Delhi

M.Sc: JMI, Delhi

Ph.D.: University of Zurich, Switzerland

Post Doc: Harvard Medical School, USA

Long term goal of our laboratory is to understand the molecular mechanisms of resistance, the most germane and fundamental issue in the cancer therapeutics with a particular focus on leukemia and glioblastoma.


We take the multi-pronged approach employing molecular biology, cell biology, genomics and proteomics to answer some of the basic questions pertaining to chemo and radiation resistance. Using clinically relevant patient samples and patient-derived cellular and mouse models developed in our lab, we have recently identified modulation of DNA repair pathways via epigenetic modifications, homotypic cell fusions and ubiquitin-proteasome system in residual resistant cells as major pathways employed by AML and GBM cells to escape therapy and relapse. We collaborate with the clinicians at ACTREC and TMH to translate the basic research findings into clinics. 

Scholar logo.png

News and Events



  • Executive committee member of AICGG (All India Congress of Genetics and Genomics)

  • Member Society for Neuroscience, USA (Sfn)

  • Member of American Society of Hematology, USA (ASH)

  • Member of American Association of Cancer Research (AACR), USA

  • Life member of ‘Life Sciences Zurich Network’, Switzerland

  • Life member of IACR (Indian Association of Cancer Research)

  • Life member of ISCB (Indian society of cell biology)

  • Life member of Society of Biological Chemists of India (SBC)

  • Life membership of Indian Society of Neuro-Oncology (ISNO)

  • Life membership of Indian Society of Hematology (ISH)

  • Twitter
  • Facebook Social Icon
  • LinkedIn Social Icon

Useful Links

November 2021: Many congratulations to Jyothi for her fantastic publication in Journal of Cell Science where she showed that DUSP6 regulates radio-sensitivity in glioblastoma by modulating the recruitment of p-DNAPKcs at DNA double-strand breaks.

November 2021: Many congratulations to Jacinth and Atanu for their publication in Heliyon where they identified novel binding partners of 14-3-3 zeta showing its role in mitochondrial biogenesis.

September 2021: Our hypothesis that cell-cell fusion events play a major role in the birth of solid tumors is online!

June 2021: Congratulations Ketki Patkar for a well deserved promotion. 

April 2021: Congratulations Madhura for winning the 'Best Oral Presentation' Award at the 12th Annual Conference of Indian Society of Neuro-Oncology (ISNO), 15-17th April 2021 hosted by Christian Medical College, Vellore

April 2021: Congratulations Debashmita for the 'Best ePoster Award' at the 12th Annual Conference of Indian Society of Neuro-Oncology (ISNO), 15-17th April 2021 hosted by Christian Medical College, Vellore

March 2021: Congratulations to Sameer for the exclusive author interview with Bio Patrika where he talks about his work on 'Mechanisms of therapy induced senescence reversal', published recently in Journal of Cell Science.

March 2021: Kudos to Saket for being awarded the 'Carl Storm International Diversity Fellowship Award' to attend and present his work at the Gordon Research Conference.

March 2021: Congratulations Saket for being awarded the competitive DMM Conference Travel Grant from The Company of Biologists! 

February 2021: Congratulations Sameer and the team for this new publication from our lab in Journal of cell science (JCS) showing spatio-temporal expression of p65 in glioma cells regulate reversal of therapy induced senescence. 

December 2020: Congratulations to Saket for the oral presentation award at National Scholars Research Meet (NRSM) held at ACTREC. 

August 2020: Congratulations Sameer and Saket for a new paper from our lab in BBA-Bioenergetics describing the metabolic rewiring of chemotherapy resistant AML cells.

July 2020: Our work delineating the mechanistic details of therapy resistance in residual cells of glioblastoma was covered by SciSoup

June 2020: Congratulations and best wishes to Atanu for acceptance of his manuscript in 'Cancer Letters'

May 2020: Work from our lab on GBM got published in Neuro-Oncology. Congratulations Ekjot and all the authors!

May 2020: Our work on breast cancer got published in Breast Cancer Research and Treatment

December 2019: Congratulations to Dr. Shilpee Dutt for Janaki Ammal - National Women Bioscientist Award (young category) 2019 by Department of Biotechnology, Govt. of India

December 2019: Congratulations to Anagha for Dr. Kalraiya Award for best oral presentation at 15th NRSM held at ACTREC.

November 2019: Congratulation to Safi Syed for getting selected for SERB National Post-doctoral Fellowship by DST, Govt. of India

August 2019: Shilpee Lab welcomes Archisman who has joined the lab as Ph.D. student.

July 2019: Congratulations to Jyothi. Her work got selected for oral presentation at FEBS conference held at Krakow, Poland.

April 2019: Shilpee Lab welcomes Safi Syed, SRF​

February 2019: Our work in collaboration with  clinicians at TMH published in Cellular Oncology 

January 2019: Congratulations to Jacinth Rajendra for successfully defending her thesis and getting Post-Doctoral fellowship in Sandeep Burma's Lab at University of Texas Southwestern Medical Center

November 2018: Vikas Ranvir joined the lab as JRF

October  2018: Manuscript reporting 7-gene pair for AML risk factor prediction published in Briefings in Bioinformatics

September 2018: Congratulations to Sameer Salunkhe for defending his work and getting the Post-doctoral fellowship in Patrick Sung's Lab at Yale University.

August 2018: Shilpee Lab welcomes Madhura and Debashmita who have joined the lab as Ph.D. students

July 2018: We bid adieu to lab's research trainees- Samadri, Gargi, and Elton.